New Drugs Declining, Research Costs Increasing, GAO Says
97570
Drug companies are becoming less innovative, with the number of new drugs being developed failing to keep pace  with the substantial increases in spending on research and development, according to congressional investigators.
142267
The drugmaker said it is weighing cost cuts that could eliminate 10 percent of its work force over a three-year period.
27790
U.S. spending on prescription drugs, hospital care and other health services is expected to double to $4.1 trillion over the next decade, up from $2.1 trillion in 2006, a government report released on Wednesday found.
604469
On the heels of reports since last May that have linked antidepressant medications to an increased risk of suicide among young users, pediatric prescriptions for the drugs have fallen 18 percent, new data finds.
140761
U.S. spending on prescription drugs,  hospital care and other health services is expected to double  to $4.1 trillion over the next decade, up from $2.1 trillion in  2006, a government report released on Wednesday found.
377721
Faced with the threat of generic competition, the company focuses its efforts on a new drug.
125115
If they want more new drugs, they shouldn't be looking at the pharmaceutical industry.
560418
The initiative is part of an effort to ferret out unpublished research consucted by pharmaceutical companies that finds medications to be ineffective or dangerous.
542932
For the past four years, the Food and Drug Administration has taken a noticeably less aggressive approach toward policing drugs that cause harmful side effects, records
171752
Patient deaths from experimental cancer drugs during initial human studies declined dramatically from 1991 to 2002, suggesting that better oversight and less-toxic medicines have made cancer research safer, a study found.
239781
The big research houses have been trimming their forecasts for global technology spending, but one forecaster thinks foreign spending will make up for a domestic slowdown.
681991
The newly empowered Democrats' vow to cut healthcare costs might spell bad news for the brand-name pharmaceutical industry, but could provide new momentum for generic drug rivals, the Wall Street Journal reported on its Web site on Tuesday.
655214
In "surprising and disappointing" news, its promising new drug fails clinical trials.
448573
A document released by the FDA outlines its concerns with GPC's lead drug.
457847
WASHINGTON - The spate of bad news about painkillers has dealt a major setback to what had been a highly promising effort to use the drugs to prevent a host of leading killers, including many types of cancer, Alzheimer&#39;s and other forms of dementia.
14335
Drug stocks took another hit Friday, a day after a veteran Food and Drug Administration researcher said that five drugs currently on the market needed closer scrutiny for possible safety risks.
161495
Progress on its lead drug remains stalled.